Imprimis Pharmaceuticals Story Overview

IMMY -- USA Stock  

USD 5.21  0.62  10.63%

Macroaxis does not monitor all media channels or aggregates social signals for Imprimis Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Imprimis Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Imprimis Pharmaceuticals. Please also check Imprimis Pharmaceuticals Hype Analysis, Imprimis Pharmaceuticals Correlation and Imprimis Pharmaceuticals Performance.
Should You Be Concerned About Imprimis Pharmaceuticals Incs Shareholders
Simply Wall StFull coverage

Read More...   

Story Momentum

This media report from simplywall.st distributed on March 8, 2018 was a factor to the next trading day price decrease.The trading delta at closing time against the next closing price was 5.24% . The trading delta at closing time when the story was published against the current closing price is 183.33% .

Similar stores for Imprimis Pharmaceuticals

Imprimis Pharmaceuticals Inc on Focus After Report of Less Shorts - The Cardinal Weeklynews
Imprimis Pharmaceuticals Inc on Focus After Report of Less Shorts The Cardinal WeeklyInvestors sentiment increased to 6.5 in 2018 Q3. Its up 4.70, from 1.8 in 2018Q2. It improved, as 0 investors sold Imprimis Pharmaceuticals, Inc. shares while.
few days ago at http://stockmarketfloor.com 
Imprimis Pharmaceuticals, Inc. closed at 6.11 on Wednesday with moved of 2.69 percent While West Pharmaceutica...
news
Imprimis Pharmaceuticals, Inc. closed at 6.11 on Wednesday with moved of 2.69 percent While West Pharmaceutical Services, Inc. closed at 107.75, 1 year low of 30.23 percent and a 1 year high of -13.86 Stock Market FloorImprimis Pharmaceuticals, Inc. s closed at 6.11 with move of 2.69 percent on Wednesday. Investors of this company earned a return of -25.20 percent on the assets ...
over a week ago at http://whatsonthorold.com 
Imprimis Pharmaceuticals Inc Stock Institutional Investors Feel Good About - Thorold News
news
Imprimis Pharmaceuticals Inc Stock Institutional Investors Feel Good About Thorold NewsImprimis Pharmaceuticals Inc institutional sentiment increased to 1.8 in 2018 Q2. Its up 0.92, from 0.88 in 2018Q1. The ratio is better, as 9 ...
over two weeks ago at http://enbulletin.com 
Imprimis Pharmaceuticals Inc Big Money 2018 Q2 Sentiment at 1.8 - The EN Bulletin
news
Imprimis Pharmaceuticals Inc Big Money 2018 Q2 Sentiment at 1.8 The EN BulletinIn Q2 2018 Imprimis Pharmaceuticals Inc big money sentiment increased to 1.8, according to SEC filings. So its up 0.92, from 2018Q1s 0.88.
over three weeks ago at http://pressoracle.com 
Imprimis Pharmaceuticals Inc Director Sells 42100.00 in Stock
news
PressOracleFull coverage
over three weeks ago at http://nasdaqclick.com 
Stock within Analysts Limelight Imprimis Pharmaceuticals, Inc.
nasdaq News
Nasdaq Click Insider Selling Imprimis Pharmaceuticals Inc Director Sells 10000 Shares of Stock Fairfield CurrentWhich Market Offer More Value iStar Inc. , Imprimis Pharmaceuticals, Inc. StockNewsGazetteFull coverage
over a month ago at http://www.mareainformativa.com 
Imprimis Pharmaceuticals Sets New 12-Month High at 4.80
news
Marea Informative Full coverage
over a month ago at http://seekingalpha.com 
Imprimis Pharmaceuticals, Inc. CEO Mark Baum on Q3 2018 Results - Earnings Call Transcript
seekingalpha News
Seeking AlphaImprimis Pharmaceuticals Announces Third Quarter 2018 Results NasdaqFull coverage
over a month ago at http://thewellesleysnews.com 
Analyst Research and Ratings MoneyGram International, Inc. , Imprimis Pharmaceuticals, Inc.
news
Analyst JournalFull coverage
over a month ago at http://nasdaqclick.com 
Recent Analysts Ratings of Stock Imprimis Pharmaceuticals, Inc.
nasdaq News
Nasdaq Click Full coverage
over two months ago at www.macroaxis.com 
Sale by Robert Kammer of 10000 shares of Imprimis Pharmaceuticals
Macroaxis News
Filed transaction by Imprimis Pharmaceuticals director. General open market or private sale of non-derivative or derivative security
over three months ago at http://floridarecorder.com 
0.88 is Imprimis Pharmaceuticals Incs Institutional Investor Sentiment
news
Florida Recorder Full coverage
over six months ago at http://heraldks.com 
Commerce Bank Lowered Its Phillips 66 Stake Imprimis Pharmaceuticals Sellers Decreased By 9.42 ...
news
Herald KSFull coverage

Shares Owned by Institutions

Shares Owned by Institutions Comparative Analysis

  Shares Owned by Institutions 
      Imprimis Pharmaceuticals Comparables 
Imprimis Pharmaceuticals is currently under evaluation in shares owned by institutions category among related companies. Shares Owned by Institutions show percentage of the outstanding shares of stock issued by a company that are currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Please also check Imprimis Pharmaceuticals Hype Analysis, Imprimis Pharmaceuticals Correlation and Imprimis Pharmaceuticals Performance. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Search macroaxis.com